scholarly journals Abnormal chest X-ray in a patient with carcinoma of the cervix.

1997 ◽  
Vol 73 (864) ◽  
pp. 671-673
Author(s):  
P. Aggarwal ◽  
R. Handa ◽  
J. P. Wali ◽  
N. Wig ◽  
A. Kumar
Keyword(s):  
X Ray ◽  
2018 ◽  
Vol 35 (10) ◽  
pp. 1032-1038 ◽  
Author(s):  
Aaron S. Weinberg ◽  
William Chang ◽  
Grace Ih ◽  
Alan Waxman ◽  
Victor F. Tapson

Objective: Computed tomography angiography is limited in the intensive care unit (ICU) due to renal insufficiency, hemodynamic instability, and difficulty transporting unstable patients. A portable ventilation/perfusion (V/Q) scan can be used. However, it is commonly believed that an abnormal chest radiograph can result in a nondiagnostic scan. In this retrospective study, we demonstrate that portable V/Q scans can be helpful in ruling in or out clinically significant pulmonary embolism (PE) despite an abnormal chest x-ray in the ICU. Design: Two physicians conducted chart reviews and original V/Q reports. A staff radiologist, with 40 years of experience, rated chest x-ray abnormalities using predetermined criteria. Setting: The study was conducted in the ICU. Patients: The first 100 consecutive patients with suspected PE who underwent a portable V/Q scan. Interventions: Those with a portable V/Q scan. Results: A normal baseline chest radiograph was found in only 6% of patients. Fifty-three percent had moderate, 24% had severe, and 10% had very-severe radiographic abnormalities. Despite the abnormal x-rays, 88% of the V/Q scans were low probability for a PE despite an average abnormal radiograph rating of moderate. A high-probability V/Q for PE was diagnosed in 3% of the population despite chest x-ray ratings of moderate to severe. Six patients had their empiric anticoagulation discontinued after obtaining the results of the V/Q scan, and no anticoagulation was started for PE after a low-probability V/Q scan. Conclusion: Despite the large percentage of moderate-to-severe x-ray abnormalities, PE can still be diagnosed (high-probability scan) in the ICU with a portable V/Q scan. Although low-probability scans do not rule out acute PE, it appeared less likely that any patient with a low-probability V/Q scan had severe hypoxemia or hemodynamic instability due to a significant PE, which was useful to clinicians and allowed them to either stop or not start anticoagulation.


1982 ◽  
Vol 17 (4) ◽  
pp. 65-70
Author(s):  
Lawrence Kaplan ◽  
Michael Young ◽  
Leonard Krilov

CJEM ◽  
2004 ◽  
Vol 6 (01) ◽  
pp. 12-21 ◽  
Author(s):  
W.N. Wong ◽  
Antonio C.H. Sek ◽  
Rick F.L. Lau ◽  
K.M. Li ◽  
Joe K.S. Leung ◽  
...  

ABSTRACT Objectives: To assess the association of diagnostic predictors available in the emergency department (ED) with the outcome diagnosis of severe acute respiratory syndrome (SARS). Methods: This retrospective cohort study describes all patients from the Amoy Garden complex who presented to an ED SARS screening clinic during a 2-month outbreak. Clinical and diagnostic predictors were recorded, along with ED diagnoses. Final diagnoses were established independently based on diagnostic tests performed after the ED visit. Associations of key predictors with the final diagnosis of SARS were described. Results: Of 821 patients, 205 had confirmed SARS, 35 undetermined SARS and 581 non-SARS. Multivariable logistic regression showed that the strongest predictors of SARS were abnormal chest x-ray (odds ratio [OR] = 17.4), subjective fever (OR = 9.7), temperature >38°C (OR = 6.4), myalgias (OR = 5.5), chills and rigors (OR = 4.0) and contact exposure (OR = 2.6). In a subset of 176 patients who had a complete blood cell count performed, the strongest predictors were temperature ≥38ºC (OR = 15.5), lymphocyte count <1000 (OR = 9.3) and abnormal chest x-ray (OR = 5.7). Diarrhea was a powerful negative predictor (OR = 0.03) of SARS. Conclusions: Two components of the World Health Organization case definition — fever and contact exposure — are helpful for ED decision-making, but respiratory symptoms do not discriminate well between SARS and non-SARS. Emergency physicians should consider the presence of diarrhea, chest x-ray findings, the absolute lymphocyte count and the platelet count as significant modifiers of disease likelihood. Prospective validation of these findings in other clinical settings is desirable.


Respiration ◽  
2003 ◽  
Vol 70 (2) ◽  
pp. 224-228
Author(s):  
Hector E. Mateo ◽  
Alpha A. Fowler
Keyword(s):  
X Ray ◽  

2020 ◽  
Vol 7 (1) ◽  
pp. e000646 ◽  
Author(s):  
Bruce Kirenga ◽  
Winters Muttamba ◽  
Alex Kayongo ◽  
Christopher Nsereko ◽  
Trishul Siddharthan ◽  
...  

RationaleDetailed data on the characteristics and outcomes of patients with COVID-19 in sub-Saharan Africa are limited.ObjectiveWe determined the clinical characteristics and treatment outcomes of patients diagnosed with COVID-19 in Uganda.MeasurementsAs of the 16 May 2020, a total of 203 cases had been confirmed. We report on the first 56 patients; 29 received hydroxychloroquine (HCQ) and 27 did not. Endpoints included admission to intensive care, mechanical ventilation or death during hospitalisation.Main resultsThe median age was 34.2 years; 67.9% were male; and 14.6% were <18 years. Up 57.1% of the patients were asymptomatic. The most common symptoms were fever (21.4%), cough (19.6%), rhinorrhea (16.1%), headache (12.5%), muscle ache (7.1%) and fatigue (7.1%). Rates of comorbidities were 10.7% (pre-existing hypertension), 10.7% (diabetes) and 7.1% (HIV), Body Mass Index (BMI) of ≥30 36.6%. 37.0% had a blood pressure (BP) of >130/90 mm Hg, and 27.8% had BP of >140/90 mm Hg. Laboratory derangements were leucopenia (10.6%), lymphopenia (11.1%) and thrombocytopenia (26.3%). Abnormal chest X-ray was observed in 14.3%. No patients reached the primary endpoint. Time to clinical recovery was shorter among patients who received HCQ, but this difference did not reach statistical significance.ConclusionMost of the patients with COVID-19 presented with mild disease and exhibited a clinical trajectory not similar to other countries. Outcomes did not differ by HCQ treatment status in line with other concluded studies on the benefit of using HCQ in the treatment of COVID-19.


2006 ◽  
Vol 355 (4) ◽  
pp. 393-393 ◽  
Author(s):  
J.R.A. Turkington ◽  
E. McAteer
Keyword(s):  
X Ray ◽  

2003 ◽  
Vol 12 (3) ◽  
pp. 94-94
Author(s):  
Praveen Bhatia ◽  
Ravish Katira ◽  
S Karthik ◽  
E. Li-Kam-Wa
Keyword(s):  
X Ray ◽  

CHEST Journal ◽  
1998 ◽  
Vol 114 (5) ◽  
pp. 1459-1462 ◽  
Author(s):  
Robert B.H. Myers ◽  
Christopher D. Morgan

2004 ◽  
Vol 13 (3) ◽  
pp. 167-168 ◽  
Author(s):  
Praveen Bhatia ◽  
S. Karthik ◽  
J.F. O'Reilly
Keyword(s):  
X Ray ◽  

Sign in / Sign up

Export Citation Format

Share Document